| Literature DB >> 22016347 |
Rossella Libé1, Amato Fratticci, Najiba Lahlou, François R Jornayvaz, Frédérique Tissier, Estelle Louiset, Jean Guibourdenche, Annick Vieillefond, Marc Zerbib, Jérôme Bertherat.
Abstract
Leydig cell tumors of the testis are the most common type of non-germ cell testicular tumors. In adult patients, gynecomastia, oligozoospermia, erectile dysfunction, and other signs of feminization can be present, whereas testosterone levels are frequently in the normal range or slightly reduced. We describe a patient with a history of impaired sexual function, as well as progressive enlargement of the left testis, without gynecomastia. Hormonal evaluation demonstrated very high testosterone, estrogen, and pan-alpha-inhibin levels. Magnetic resonance imaging revealed the presence of left testicular hypertrophy without evidence of testicular mass. After left orchiectomy, histologic examination confirmed the diagnosis of Leydig cell tumor, and steroid hormone levels normalized. A heterozygous missense somatic gsp mutation (R201C) was found in tumoral tissue, whereas no mutation was found in the surrounding normal tissue or in leukocyte DNA. This case provides evidence that somatic activating gsp mutation in Leydig cells may result in tumor development, leading to overexpression of the inhibin alpha subunit and hyperactivity of the testosterone biosynthetic pathway.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22016347 DOI: 10.2164/jandrol.111.013441
Source DB: PubMed Journal: J Androl ISSN: 0196-3635